# OnCo record tinengotinib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tinengotinib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tinengotinib" ;
  schema:name "Tinengotinib"@en ;
  schema:description "A next-generation FGFR inhibitor designed to work after pemigatinib or futibatinib stop working, now in a global phase 3."@en ;
  schema:url <https://onco.cc/drugs/tinengotinib/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05948475>, <https://clinicaltrials.gov/study/NCT05253053> ;
  onco:status "phase-3" ;
  onco:modality "Small-molecule multi-kinase inhibitor (FGFR1-3, VEGFR, Aurora, JAK)" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/fgfr2/> ;
  onco:companies <https://onco.cc/companies/transthera/> ;
  onco:terms <https://onco.cc/terms/fgfr2-fusion/> ;
  onco:trials <https://onco.cc/trials/first-308/>, <https://onco.cc/trials/nct07052253/>, <https://onco.cc/trials/nct07498478/>, <https://onco.cc/trials/nct05948475/> .